Related Experiment Video
Updated: May 5, 2026

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
Published on: April 7, 2017
miR-203, a tumor suppressor frequently down-regulated by promoter hypermethylation in rhabdomyosarcoma
Yarui Diao1, Xing Guo, Lei Jiang
1From the Biomedical Research Institute, Shenzhen Peking University-Hong Kong University of Science and Technology Medical Center, 518036 Shenzhen.
Abstract:
Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma found in children and young adults. It is characterized by the expression of a number of skeletal muscle-specific proteins, including MyoD and muscle α-actin. However, unlike normal myoblasts, RMS cells differentiate poorly both in vivo and in culture. As microRNAs are known to regulate tumorigenesis, intensive efforts have been made to identify microRNAs that are involved in RMS development. In this work, we found that miR-203 was frequently down-regulated by promoter hypermethylation in both RMS cell lines and RMS biopsies and could be reactivated by DNA-demethylating agents. Re-expression of miR-203 in RMS cells inhibited their migration and proliferation and promoted terminal myogenic differentiation. Mechanistically, miR-203 exerts its tumor-suppressive effect by directly targeting p63 and leukemia inhibitory factor receptor in RMS cells, which promotes myogenic differentiation by inhibiting the Notch and the JAK1/STAT1/STAT3 pathways, respectively. Our work reveals that miR-203 functions as a tumor suppressor in RMS development.
Insights
MicroRNA-203 (miR-203) acts as a tumor suppressor in pediatric rhabdomyosarcoma (RMS). Reactivating miR-203 inhibits RMS cell growth and promotes differentiation by targeting key developmental pathways.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Rhabdomyosarcoma (RMS) is a prevalent pediatric soft tissue sarcoma.
- RMS cells exhibit poor differentiation compared to normal myoblasts.
- MicroRNAs are implicated in tumorigenesis and cancer development.
Purpose of the Study:
- To investigate the role of microRNAs in rhabdomyosarcoma development.
- To identify specific microRNAs involved in RMS pathogenesis and differentiation.
- To elucidate the molecular mechanisms underlying microRNA regulation in RMS.
Main Methods:
- Analysis of miR-203 expression in RMS cell lines and patient biopsies.
- Investigating miR-203 regulation via promoter hypermethylation and DNA demethylating agents.
- Assessing the functional impact of miR-203 re-expression on RMS cell behavior (migration, proliferation, differentiation).
- Identifying direct molecular targets of miR-203 (p63, LIFR) and downstream signaling pathways (Notch, JAK/STAT).
Main Results:
- miR-203 is frequently downregulated in RMS due to promoter hypermethylation.
- DNA demethylating agents can reactivate miR-203 expression in RMS.
- Restoring miR-203 suppresses RMS cell migration and proliferation.
- miR-203 re-expression promotes terminal myogenic differentiation in RMS cells.
- miR-203 directly targets p63 and LIFR, inhibiting Notch and JAK/STAT pathways.
Conclusions:
- miR-203 functions as a tumor suppressor in rhabdomyosarcoma.
- miR-203's tumor-suppressive activity is mediated by targeting p63 and LIFR.
- Restoration of miR-203 holds therapeutic potential for treating RMS.
Related Concept Videos
MicroRNAs
MicroRNAs
Abnormal Proliferation
Epigenetic Regulation
Epigenetic Regulation
X-chromosome...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

